ALKERMES | DŁUG



Debt Zmiana Data
AbbVie USD 69.89B 2.74B 2025-03
Acadia Pharmaceuticals USD 56.29M 56.29M 2025-06
ALKERMES USD 72.68M 72.68M 2025-06
Amgen USD 56.2B 1.18B 2025-06
Biogen USD 6.59B 296.8M 2025-06
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Bristol-Myers Squibb USD 50.93B 1.22B 2025-06
Eli Lilly USD 39.9B 1.39B 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Ionis Pharmaceuticals USD 1.42B 169.27M 2025-06
J&J USD 52.25B 15.62B 2025-03
Malin Corporation EUR 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Otsuka Holdings JPY 252.7B 63.32B 2025-03
Pfizer USD 60.93B 1.18B 2025-06
Regeneron Pharmaceuticals USD 2.71B 300K 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


ALKERMES DŁUG - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.